Prescription drug · NDA
ATNAA atropine and pralidoxime chloride Auto-Injector (Atropine and pralidoxime chloride) NDC 11704-777
Kit · Intramuscular · Meridian Medical Technologies, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 11704-777-01 | 11704077701 | 1 KIT in 1 CARTON (11704-777-01) * .7 mL in 1 SYRINGE, GLASS * 2 mL in 1 SYRINGE, GLASSMarketed from Jan 17, 2002 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- ATNAA atropine and pralidoxime chloride Auto-InjectorSuffix: Auto-Injector
- Generic name (nonproprietary)
- atropine and pralidoxime chloride
- Dosage form
- Kit
- Route
- Intramuscular
- Labeler
- Meridian Medical Technologies, LLCNDC labeler code 11704
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021175
- Marketing start
- Listing expires
- Identifiers
- Product ID 11704-777_ad537254-90f8-4732-9f32-bee3e1cae81aSPL ID ad537254-90f8-4732-9f32-bee3e1cae81aSPL set ID 596c7a8f-27cd-4de2-9491-476f43570b8bRxCUI 727415
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N411704077701followed by a unit qualifier and the quantityPackage 11704-0777-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ATNAA is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ATNAA, a combination of atropine, a cholinergic muscarinic antagonist, and pralidoxime chloride, a cholinesterase reactivator, is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 11704-777
- What is NDC 11704-777?
- 11704-777 is the product NDC for ATNAA atropine and pralidoxime chloride Auto-Injector kit, listed with the FDA by Meridian Medical Technologies, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- ATNAA atropine and pralidoxime chloride Auto-Injector (Atropine and pralidoxime chloride).
- Who is the labeler?
- Meridian Medical Technologies, LLC, NDC labeler code 11704. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for ATNAA atropine and pralidoxime chloride Auto-Injector?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.